{"schema":"sb.node.v1","id":"sb:e/1ccaf7a7b68e32af55cbc6a4","kind":"entity","label":{"text":"fda","locale":"en"},"identity":{"anchor":"label:en:fda","strength":"label"},"asOf":{"knowledgeCutoff":"2026-10-29T21:52:40.283342+00:00","releaseId":"sb-013b9f1563a4","snapshot":"deploy 7cc6feb3a91f8fbaf0d19db551d3cdb3e32310c1"},"lens":{"kind":"public"},"build":{"plane":"projected","builtFrom":["entity_graph.slim.json","entity_receipts (deploy asset)","event_graph.json","truth_records (deploy asset)","corroborated_record.json"],"rule":"node-projection.entity@v1"},"standing":{"evidence":{"supporting":2735,"separatePublishers":241,"basis":"documents that mention the subject and the outlets that carried them; a mention is evidence the referent is in use, not evidence about any claim","receiptsOnTopic":{"state":"measured","share":0.521,"named":1425,"of":2735,"basis":"documents whose own title or summary lead names the subject, over every counted document that mentions it anywhere (the entity graph's measurement); receipts are drawn only from rows whose own title or URL names the subject (the entity graph's subject gate)"}},"admission":{"state":"canonical","kind":"legacy","kindBasis":"seed","reason":"entity graph provenance 'curated'; part of the hand-written seed vocabulary that predates machine promotion; no receipt exists","policy":"promotion (seed vocabulary; no receipt)"},"disposition":{"state":"served","reason":"public record"},"validity":{"from":"2026-04-06","to":"2026-10-27","basis":"first and last day we saw it mentioned; not the subject's own lifetime"},"measurement":{"state":"partial","blind":["assertion coverage 0.353: about 65% of mentions carry no typed assertion"]}},"dimensions":{"domains":["pharma-regulatory","biotech_pharma","medical_devices"],"activeDays":159,"assertions":{"regulatory-approval":937,"military-action":10,"election":8,"utterance":7,"legal-ruling":2,"meeting-visit":1}},"up":[],"upNote":"An entity is a root: it is contained by nothing. Pan out by following R.","children":{"count":7,"byKind":{"observation":7},"withheld":{"state":"withheld","count":5,"reason":"5 receipts withheld: no source link (the same rule the topic record applies)"},"items":[{"id":"sb:o/d7b414935013babba5d0f17b","kind":"observation","label":"PR Newswire · 2026-10-27 · FDA Selects Patient-Led Nonprofit to Develop Pancreatitis Flare Endpoint for Clinical Trials","url":"https://www.prnewswire.com/news-releases/fda-selects-patient-led-nonprofit-to-develop-pancreatitis-flare-endpoint-for-clinical-trials-302920320.html","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/664ea1ee8e7ec114babaa48e","kind":"observation","label":"Medical Daily · 2026-10-27 · FDA Launches New Neuroscience Program to Improve Alzheimer's Prevention Trials and Support Future Treatments for Brain Disorders","url":"https://www.medicaldaily.com/fda-neuroscience-program-alzheimers-prevention-480457","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/b88bf90047d2d653ac11e90a","kind":"observation","label":"FDA Drug News · 2026-10-27 · FDA Drug Topics Webinars","url":"http://www.fda.gov/drugs/information-health-care-professionals-drugs/fda-drug-topics-webinars","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/77caeda5bf61b0b5e3208a0d","kind":"observation","label":"J Gastrointest Cancer · 2026-10-26 · Signal Mining of Adverse Events of Antiangiogenic Drugs in Colorectal Cancer Based on the FDA Adverse Event Reporting System (FAERS) Database.","url":"https://doi.org/10.1007/s12029-026-01613-9","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/e4b24189e959d99c30f6bf02","kind":"observation","label":"Intelligent Living · 2026-10-26 · Over 1,000 FDA-Cleared AI Devices: Where They Actually Work in Hospitals","url":"https://www.intelligentliving.co/fda-cleared-ai-devices-hospitals/","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/b1167fd8af1543b28d331cd2","kind":"observation","label":"Psychedelic Alpha · 2026-10-26 · Mostly Supportive, Somewhat Divided: Stakeholders Respond to FDA’s Psychedelics Docket","url":"https://psychedelicalpha.com/news/mostly-supportive-somewhat-divided-stakeholders-respond-to-fdas-psychedelics-docket/","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/56c102b2f467ae7848cca089","kind":"observation","label":"Tech Times · 2026-10-26 · Israel Opens First National MDMA-Psilocybin PTSD Trial After FDA Rejection","url":"https://www.techtimes.com/articles/329458/20261025/israel-opens-first-national-mdma-psilocybin-ptsd-trial-after-fda-rejection.htm","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}}],"cursor":null,"order":"newest first; we keep the 7 newest receipts for this entity whose own title or URL (the entity graph's subject gate) names it; each says which in match. Its other observations are counted in standing.evidence.supporting but are not addressable in v1"},"relations":{"count":18,"byKind":{"claim":8,"co-mentioned":10},"items":[{"id":"sb:p/82b55751eb0af2b1c9a80355","kind":"claim","label":"FDA approves talazoparib with enzalutamide for metastatic androgen pathway modulation-naïve or -sensitive prostate cancer with HRR gene mutations — corroborated","role":"named-in","relationKind":"claim","members":1},{"id":"sb:p/11a94edbdc33b5546f69af2e","kind":"claim","label":"FDA Launches New Accelerator for Alzheimer’s Disease Prevention — reported by two","role":"named-in","relationKind":"claim","members":1},{"id":"sb:p/bad3fb49f228b1baf0575ad9","kind":"claim","label":"Lord's Mark Industries Secures US FDA Registration For 200 Products For December US Exports — could not check","role":"named-in","relationKind":"claim","members":1},{"id":"sb:p/5ce3df76e6aa824ba9bc2039","kind":"claim","label":"fda approved over-the-counter weight loss drugs 2026 — could not check","role":"named-in","relationKind":"claim","members":1},{"id":"sb:p/5c716488f6800510045dab21","kind":"claim","label":"STAT+: FDA offers new details on quicker approval pathway for personalized gene therapies — single source","role":"named-in","relationKind":"claim","members":1},{"id":"sb:p/36fb2199d0940e1a8a6d57d5","kind":"claim","label":"FDA Advisory No.2026-1681 || Public Health Warning Against the Purchase and Use of the Unregistered Medical Device Product “FIRST LINE FINGERTIP PULSE OXIMETER (YK-84C)” — single source","role":"named-in","relationKind":"claim","members":1},{"id":"sb:p/779d45175206eb5e9046fc66","kind":"claim","label":"Coreline Soft Receives U.S. FDA 510(k) Clearance for AVIEW Aorta Metrics, Expanding Its Chest CT AI Portfolio in the U.S. — single source","role":"named-in","relationKind":"claim","members":1},{"id":"sb:p/fde8d45230f01b77fec7beba","kind":"claim","label":"FDA Grants Breakthrough Device Designation to Pharaoh Neuro's Neurapheresis™ CSF Management System — single source","role":"named-in","relationKind":"claim","members":1},{"kind":"relation","label":"co-mentioned with drug administration (922 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/a6cee2b412dbbbbfb39e47cd"},{"kind":"relation","label":"co-mentioned with u.s. food (374 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/082f5eb6f7a2436c2194fadf"}],"cursor":"c1.eyJpZCI6InNiOmUvMWNjYWY3YTdiNjhlMzJhZjU1Y2JjNmE0IiwibCI6InJlbGF0aW9ucyIsIm8iOjEwLCJrIjpudWxsLCJhIjoiMjAyNi0xMC0yOVQyMTo1Mjo0MC4yODMzNDIrMDA6MDAifQ","order":"situations first, then claims (the subject's own maintained record, then site-wide corroborated clusters; each label ends with its standing), then co-mentions by shared documents, descending. Co-mentions are the ten strongest the entity graph keeps per entity"},"edge":{"state":"continues"},"links":{"rest":"/api/v1/node/e/1ccaf7a7b68e32af55cbc6a4","mcp":"traverse {\"id\":\"sb:e/1ccaf7a7b68e32af55cbc6a4\"}","page":"/entity/fda/"},"limits":{"levelsPerCall":1,"pageSize":10,"maxPageSize":50,"membersMax":50,"statement":"One level per call: depth is 1 and only 1, and there is no whole-graph dump. pageSize 1-50 (default 10); a page limit is a cursor, never an edge. Members are listed up to 50. At most 60 traverse calls a minute per caller (runaway-loop protection, not a meter). One knowledge cutoff is served: the deploy's."},"actions":[{"verb":"unfold","lit":true,"effect":"read","layer":"free-record","call":"traverse {\"id\":\"sb:e/1ccaf7a7b68e32af55cbc6a4\",\"level\":\"children\"}"},{"verb":"fold","lit":true,"effect":"read","layer":"free-record","call":"traverse {\"id\":\"sb:e/1ccaf7a7b68e32af55cbc6a4\"}"},{"verb":"panOut","lit":false,"effect":"read","layer":"free-record","reason":"An entity is a root: it is contained by nothing. Pan out by following R."},{"verb":"follow","lit":true,"effect":"read","layer":"free-record","call":"traverse {\"id\":\"sb:e/1ccaf7a7b68e32af55cbc6a4\",\"level\":\"relations\"}"},{"verb":"receipts","lit":false,"effect":"read","layer":"free-record","reason":"receipts are the observations below this node; unfold to reach them"},{"verb":"edge","lit":true,"effect":"read","layer":"free-record","call":"traverse {\"id\":\"sb:e/1ccaf7a7b68e32af55cbc6a4\"}"},{"verb":"asOf","lit":false,"effect":"read","layer":"free-record","reason":"v1 serves one knowledge cutoff, this deploy's; walking an earlier cutoff needs retained history, which v1 does not keep"},{"verb":"switchObserver","lit":false,"effect":"read","layer":"free-record","reason":"the public record is the same for every observer; traversal through a Watch's lens is not served in v1"},{"verb":"readOriginal","lit":false,"effect":"read","layer":"free-record","reason":"no translation is applied on this node; every label is the source's own text"},{"verb":"save","lit":false,"effect":"watch-declaration","layer":"watch","reason":"saving applies to a configured Watch; configure one around this node first (free), then save it"},{"verb":"deliver","lit":false,"effect":"watch-declaration","layer":"watch","reason":"delivery applies to a saved Watch"},{"verb":"format","lit":false,"effect":"watch-declaration","layer":"watch","reason":"output format applies to a saved Watch"},{"verb":"deltaR","lit":false,"effect":"read","layer":"watch","reason":"Delta R needs a saved Watch with a previous reading"},{"verb":"read","lit":false,"effect":"read","layer":"one-time-read","reason":"one-time Reads are not offered through this door; use ask"}]}